... $1.5 billion in 2006-07 mainly due to revenues from two authorised generic products and a 180-day exclusivity for the generic version of GSK’s Zofran. ...
Generics have, of course, played their role in thinning out product revenues as well, with competition for GSK's Zofran (ondansetron), ...
The maternity management revenues reflect reductions from the combined effects of Zofran becoming generic and softness in the market for certain clinical ...
Several key drugs also faced generic competition, including the antidepressant Wellbutrin, Zofran for nausea and Coreg IR for hypertension. ...
Sales of Zofran (-86% to £32 million), Flixonase/Flonase (-23% to £49 million) and Wellbutrin XL (-41% to £114 million ) decreased as a result of generic ...
The maternity management revenues reflect reductions from the combined effects of Zofran becoming generic and softness in the market for certain clinical ...
Several key drugs also faced generic competition, including the antidepressant Wellbutrin, Zofran for nausea and Coreg IR for hypertension. ...
Glaxo has also been under pressure from generic competition for its anti-nausea drug Zofran and antidepressant Wellbutrin, and is trading against a strong ...
all 5 news articles
To boot, it’s exclusivity on nausea drug, Zofran, ended last quarter. Dr Reddy’s was selling the drug with limited competition in US for the first six ...